Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Recruiting · NCT06558604 · Registry updated 2026-07-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2026-07-10 | NCT06558604 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BeiGene | 47 |
| Hoffmann-La Roche | 280 |
| The Lymphoma Academic Research Organisation | 20 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHP - Hopital Henri Mondor | Créteil | France | 6 |
| Az Sint-Jan Brugge - Oostende Av | Bruges | Belgium | 1 |
| Centre Henri Becquerel | Rouen | France | 71 |
| CHU de Liege | Liège | Belgium | 3 |
| Chu de Lille - Hopital Claude Huriez | Lille | France | 2 |
| CHU de Montpellier | Montpellier | France | 48 |
| CHU de Nantes | Nantes | France | 60 |
| Chu de Reims - Hopital Robert Debre | Reims | France | 2 |
| Chu Dijon Bourgogne | Dijon | France | 31 |
| Chu Lyon-Sud | Pierre-Bénite | France | 1 |
| Chu Pontchaillou | Rennes | France | 8 |
| CHU UCL Namur - Site Godinne | Yvoir | Belgium | 5 |
| Hopitaux Universitaires de Strasbourg (Hus) | Strasbourg | France | 1 |
| Institut Curie | Saint-Cloud | France | 12 |
| Institut Jules Bordet | Brussels | Belgium | 23 |
| Institut Paoli Calmettes | Marseille | France | 49 |